Pharmaceutical

BioVersys and GSK expand their partnership for TB treatment alpibectir

BioVersys and GSK have announced the expansion of their partnership to expedite the clinical development of alpibectir for tuberculosis (TB).

May 9, 2024 - 00:00
BioVersys and GSK expand their partnership for TB treatment alpibectir
BioVersys and GSK have announced the expansion of their partnership to expedite the clinical development of alpibectir for tuberculosis (TB).
Read the original article

Tags:

Previous Article

How six trends are driving pharmaceutical milling  

Next Article

TerSera’s ZOLADEX LA gains Health Canada approval for breast cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

KBI Biopharma and Argonaut form drug manufacturing alliance

KBI Biopharma and Argonaut form drug manufacturing alli...

Jan 17, 2024

Tevogen Bio partners Microsoft for HPV treatment

Tevogen Bio partners Microsoft for HPV treatment

Nov 7, 2024

STAT+: The woman behind AstraZeneca’s cancer winning streak

STAT+: The woman behind AstraZeneca’s cancer winning st...

Jun 6, 2023